Viewing Study NCT06517433


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2025-12-31 @ 11:57 PM
Study NCT ID: NCT06517433
Status: COMPLETED
Last Update Posted: 2024-07-24
First Post: 2024-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2b
Sponsor: Mersana Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module